IP Forecast: Novartis To Fight Antitrust Row Over Drug Patent

By Andrew Karpan · October 5, 2023, 9:38 PM EDT

Novartis is set to oppose an appeal at the Second Circuit from a rival seeking to restore an antitrust suit accusing it of hiding things from the patent office to illegally...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Regeneron Pharmaceuticals, Inc v. Novartis Pharma AG

Case Number

Court

Appellate - 2nd Circuit

Nature of Suit

3410 STATUTES-Antitrust

Date Filed

March 01, 2022

Recent Articles By Andrew

August 09, 2024
Valeant's Legal Gripe A Total 'Nothingburger,' Justices Told
July 11, 2024
GSK Asks Judge To Rule In Teva IP Case, Citing Opioid Deals
July 09, 2024
South Africa Drops J&J Probe After TB Drug Price Cuts
June 26, 2024
Ga. High Court Told To Skip Inventor's 'Clerical Mistake' Fight
June 13, 2024
IP Forecast: Cooley Atty Faces DQ Bid Over Past Patent Work
June 10, 2024
5 Teva Inhaler Patents Kicked Out Of Orange Book
May 31, 2024
Samsung Strikes First With Smart Ring IP Suit Against Oura
May 22, 2024
Inventor To Take $102M IP Malpractice Row To Ga. High Court
May 21, 2024
Sens. Challenge Pharma Lobbyist Over Patent Abuse
May 14, 2024
The PREP Immunity Question Won't Be Decided Yet